Sumanta Pal is an Oncologist in Newport Beach, California. Dr. Pal is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Antonio Gasbarrini practices in Rome, Italy. Gasbarrini is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Their top areas of expertise are Small Bowel Bacterial Overgrowth, Viral Gastroenteritis, Helicobacter Pylori Infection, Liver Transplant, and Endoscopy.

Stefan Zeuzem practices in Frankfurt Am Main, Germany. Mr. Zeuzem is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Gastrostomy.

Ramona Dadu is an Endocrinologist in Houston, Texas. Dr. Dadu is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Thyroidectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.

Harriet Kluger is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Kluger is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.

Jaume Capdevila practices in Barcelona, Spain. Capdevila is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Their top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Medullary Thyroid Carcinoma, Thyroid Cancer, and Appendectomy.

Antongiulio Faggiano practices in Rome, Italy. Faggiano is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Their top areas of expertise are Neuroendocrine Tumor, Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Parathyroidectomy, and Thyroidectomy.

Jie Liu practices in Yuquan, China. Mr. Liu is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Cerebral Hypoxia, Liver Cancer, Diarrhea, Endoscopy, and Thyroidectomy.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.

Jean-charles Soria practices in Villejuif, France. Soria is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.

Marcia Brose is an Oncologist in Philadelphia, Pennsylvania. Dr. Brose is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Brose is currently accepting new patients.

Antoine Italiano practices in Villejuif, France. Mr. Italiano is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, Tissue Biopsy, and Hysterectomy.

Alessandro Antonelli practices in Verona, Italy. Antonelli is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Their top areas of expertise are Graves Disease, Renal Cell Carcinoma (RCC), Hyperthyroidism, Nephrectomy, and Prostatectomy.

Martin Fassnacht practices in Wuerzburg, Germany. Mr. Fassnacht is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Adrenal Gland Adenoma, Gastric Bypass, and Lymphadenectomy.

Mark Agulnik is an Oncologist in Los Angeles, California. Dr. Agulnik is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Adult Soft Tissue Sarcoma, Synovial Sarcoma, Angiosarcoma, Osteotomy, and Colonoscopy.

Hideo Baba practices in Kumamoto, Japan. Mr. Baba is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Colorectal Cancer, Esophageal Cancer, Stomach Cancer, Hepatectomy, and Pancreaticoduodenectomy.

Mimi Hu is an Endocrinologist in Houston, Texas. Dr. Hu is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Hypercalcemia, Thyroidectomy, and Tissue Biopsy.

Francis Worden is an Oncologist and a Pediatrics provider in Ann Arbor, Michigan. Dr. Worden is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Rossella Elisei practices in Pisa, Italy. Ms. Elisei is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Pancreaticoduodenectomy.